PRELIMINARYPROGRAMME

EXCEMED Blended Education7th EMEA forum on cardiovascular risks

Live intervention in Amsterdam, The Netherlands24 November 2018

32

OverviewIt is well established that high blood pressure is the most important cardiovascular risk factor andthe leading cause of death worldwide. In the near future the prevalence of hypertension will increaseworldwide despite the global effort to combat this important disease. Recent American andEuropean Guidelines for hypertension have stimulated discussion about on defining more ambitioustargets for antihypertensive treatment, thereby supporting the need for more aggressive treatment.On the other hand, it is necessary to examine whether study results supporting the new targets,including the SPRINT trial, are truly applicable in clinical practice. Another new aspect raised byGuidelines is the primary role of fixed-dose combination therapy. It is therefore necessary toexamine all the different available combinations to understand their differences and specificindications.

An EXCEMED Learning JourneyEXCEMED has designed a comprehensive Blended Learning Journey to increase knowledge incardiovascular disease with a specific focus on hypertension. This programme will address the mostrecent advancements of research in the area of this cardiovascular risk factor and will discuss thebest approach for clinical management of the complex hypertensive patient in daily practice. Amultistep approach will be used, encompassing web-based and live activities. All activities – in-person and online – will involve the full interaction of learners.

Learning objectivesBy attending this programme, you will be able to:• Discuss the most recent indications from American and European Guidelines concerning the bloodpressure values which should be considered to start antihypertensive treatment and the bloodpressure targets for therapy in patients with complicated and non complicated hypertension.

• Personalize antihypertensive treatment by presenting the more recent novelties in the combinationtherapy, including the fixed-dose based strategy and the indications to prescribe a combination of abeta-blocker with a calcium antagonist.

• Optimize the use of beta-blockers in patients with different cardiovascular complications includingdiabetes, coronary artery disease and heart failure.

7th EMEA forum on cardiovascular risks

Target audienceThis programme is designed for cardiologists and internists involved in preventing and managingpatients with cardiovascular risk factors or who are experiencing cardiovascular diseases.

ChairGiuseppe Mancia University of Milano-BicoccaMilan, Italy

ONLINEPREPARATORYTUTORIALSOctober 2018

LIVEINTERVENTION24 November 2018

ONLINEIN-DEPTHTUTORIALS

December 2018

ONLINEPREPARATORYTUTORIALSOctober 2018

LIVEINTERVENTION24 November 2018

ONLINEIN-DEPTHTUTORIALS

December 2018

54

CME ProviderEXCEMED is a non profit foundation dedicated, since the last four decades, to the development of high-quality medical education programmes all over the world.

EXCEMED adheres to the guidelines and standards of the European Accreditation Council forContinuing Medical Education (EACCME®) which states that continuing medical education must bebalanced, independent, objective and scientifically rigorous.

EXCEMED - Excellence in Medical EducationSenior Programme Manager: Alessia AddessiT +39 06 420413 591 - F +39 06 420413 677alessia.addessi@excemed.org

Medical Advisor: Stefano Taddei

EXCEMED adheres to the principles of the Good CME Practice group (gCMEp).

Register now and receive the EXCEMED invitation to start your Learning Journey!

PREPARATORY OVERVIEWThe first exclusive tutorial is a video contribution with Professor G. Mancia (Italy) on bloodpressure targets of hypertensive patients.

Learning objectives• Define the new blood pressure target for antihypertensive treatment as defined by recentESH/ESC Guidelines.

• Discuss the beneficial effects of such new blood pressure targets, but also the relatedproblems caused by tolerability and rug discontinuation.

• Underline the fact that despite blood pressure normalization the residual risk of hypertensivepatients is still higher than the normotensive population.

VIDEO-LECTUREThe second contribution is a video talk by Professor G. Grassi (Italy) on sympathetic activity andhypertension.

Learning objectives• Evaluate the role of sympathetic activity in the pathophysiology of hypertension and in thedevelopment and progression of its target organ damage

• Assess the level of activation of sympathetic activity in hypertensive patients by using firstlevels or advanced methods, including microneurography

• Appraise the value of different antihypertensive drugs in reducing sympathetic activity thusproperly implementing patient treatment in clinical practice

ONLINE PREPARATORY TUTORIALSOctober 2018

ONLINEPREPARATORYTUTORIALSOctober 2018

LIVEINTERVENTION24 November 2018

ONLINEIN-DEPTHTUTORIALS

December 2018

76

The live component of the Learning Journey is a combination of frontal lectures, panel discussion andinteractive case studies.

VenueThis conference will take place at the:Park Inn Radisson City West hotelLa Guardiaweg 59 NL-1043 DEAmsterdam, The Netherlands

LanguageThe official language of the live intervention will be English.

Continuing Medical EducationAn application has been made to the EBAC® for CME accreditation of “7th EMEA forum oncardiovascular risks” to be held on 24 November 2018 in Amsterdam, The Netherlands.

LIVE INTERVENTION24 November 2018 FACULTY

Kennedy CruickshankDiabetes and Nutritional Sciences DivisionKing’s College LondonLondon, UK

Giuseppe ManciaUniversity of Milano-BicoccaMilan, Italy

Leonidas PoulimenosDepartment of CardiologyAsklepeion HospitalAthens, Greece

Harry A.J. Struijker-BoudierMaastricht UniversityMaastricht, The Netherlands

Brian TomlinsonDepartment of Medicine and TherapeuticsThe Chinese University of Hong KongHong Kong SAR

98

Saturday, 24 November 2018

08.15 Welcome and introductionGiuseppe Mancia (Italy)

Chair: Giuseppe Mancia (Italy)

08.30 L1: Blood pressure targets in hypertensive patients: European GuidelinesGiuseppe Mancia (Italy)

08.50 L2: Should increased heart rate be treated in hypertension?Harry A.J. Struijker-Boudier (The Netherlands)

09.10 L3: New possibilities for the fixed-dose combination treatment in hypertensionLeonidas Poulimenos (Greece)

09.30 Panel discussion

09.50 Coffee break

Chair: Giuseppe Mancia (Italy)

10.10 L4: Best practice in the management of stable chronic anginaLeonidas Poulimenos (Greece)

10.30 L5: From hypertension via the heart and arteries to heart failure: preventionstrategiesKennedy Cruickshank (UK)

10.50 L6: Use of betablockers in diabetesBrian Tomlinson (Hong Kong)

11.10 Panel discussion

Session I

Session II

Legend: L : Lecture : Discussion : Working groups

PROGRAMME

11.30 Working groupsThis session includes two different parallel workshops, each lasting 45 minutes. Participants will be divided into groups and will attend both workshops in rotation. By the end of the session each participant will have attended both workshops.

WG1: Complex patient with hypertension: when we need a beta-blockerHarry A.J. Struijker-Boudier (The Netherlands)

WG2: How to optimize treatment in patients with heart failureBrian Tomlinson (Hong Kong)

13.00 Take home messages from the working groups and wrap up

13.15 Closing remarksGiuseppe Mancia (Italy)

13.20 End of the live intervention

Closing lunch

Session III

The registration fee for the whole blended programme is EUR 150,00 and includes:• Access to the online tutorials• Scientific sessions• Coffee break and lunch• Educational materials• Certificate of attendanceDinner is not included

For registration, accommodation and any logistic inquiry, please contact:Meridiano Congress InternationalEvent Manager: Claudia MaddalenaT +39 06 88595 232 - F +39 06 88595 234claudia.maddalena@meridiano.it

www.excemed.org

1110

ONLINEPREPARATORYTUTORIALSOctober 2018

LIVEINTERVENTION24 November 2018

ONLINEIN-DEPTHTUTORIALS

December 2018

ONLINE IN-DEPTH TUTORIALDecember 2018

Continue your Learning Journey after the live intervention!

INTERACTIVE CLINICAL CASEAn interactive clinical case on heart failure will help you delve deeper into content and put thekey messages of this Learning Journey into clinical context.

Learning objectives• Describe the clinical conditions of the patient and if a better treatment might improve theprognosis

• Illustrate optimal treatment according to the evidence of controlled clinical trials• Identify how the treatment might be improved and the best strategy to manage the follow-up

Follow us on

Visit

Registration

ONLINEPREPARATORYTUTORIALSOctober 2018

LIVEINTERVENTION24 November 2018

ONLINEIN-DEPTHTUTORIALS

December 2018

All EXCEMED programmes are organized solely to promote the exchange and dissemination of scientific andmedical information. No forms of promotional activities are permitted. There may be presentations discussinginvestigational uses of various products. These views are the responsibility of the named speakers, and do notrepresent an endorsement or recommendation on the part of EXCEMED. This independent programme ismade possible thanks to educational grants received from: Merck KGaA Darmstadt Germany and San RaffaeleHospital Milan.

12

EXCEMED - Excellence in Medical Education14, Rue du Rhône - 1204 Geneva, Switzerland

Improving the patient's life through medical educationwww.excemed.org

Copyright © EXCEMED, 2018. All rights reserved.